SEARCH
ProFound AI
Discover the ProFound impact of artificial intelligence for digital breast tomosynthesis
FDA Cleared, CE Mark, Health Canada Licensed
Discover the Xoft Electronic Brachytherapy (eBx) System
Explore Breakthrough Technology Delivering Excellent Results
<
>
Who is iCAD?
iCAD is a global medical technology leader providing innovative cancer detection and therapy solutions. We work passionately to provide precise, powerful healthcare solutions expertly engineered to optimize operational efficiency, clinician confidence and patient outcomes.
Recent News
August 1, 2019
iCAD Reports Second Quarter 2019 Financial Results
July 29, 2019
iCAD to Report Second Quarter 2019 Financial Results On Thursday, August 1
July 11, 2019
iCAD’s ProFound AI™ for 2D Mammography Receives CE Mark Approval
July 10, 2019
SimonMed Imaging Implements the First FDA-Cleared 3D Tomosynthesis Software Using Artificial Intelligence
June 18, 2019
iCAD to Participate in The JMP Securities Life Sciences Conference And Piper Jaffray Heartland Summit
» View All News »
CONNECT
© 2018, iCAD Inc. All rights reserved. iCAD, the iCAD logo,, PowerLook, ProFound AI, ProFound, Xoft, the Xoft logo, Axxent, Electronic Brachytherapy System and eBx are trademarks of iCAD, Inc. Reproduction of any of the material contained herein in any format or media without the express written permission of iCAD, Inc. is prohibited.
